Founded in 2003, EBR Systems develops wireless cardiac stimulation tech, initially focusing on leadless CRT to improve heart failure treatment. Their WiSE tech aims to expand into the $11B cardiac rhythm management market.
EBR Systems is developing the world’s first and only leadless pacemaker for heart failure.
In this interview, EBR Systems CEO and President John McCutcheon explains how this tiny device will change the way cardiologists treat heart patients.
Heart failure affects nearly 6 million people in the United States and more than 25 million globally, with the size of the opportunity potentially worth up to US$10 billion.
